Pfizer CEO sees annual Covid-19 vaccine rather than frequent boosters

23/1/2022 5:21:00 AM

Pfizer CEO sees annual Covid-19 vaccine rather than frequent boosters

https://str.sg/wAstJERUSALEM (REUTERS) - Pfizer Chief Executive Albert Bourla said on Saturday (Jan 23) that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.Pfizer/BioNtech's Covid-19 vaccine has shown to be effective against severe disease and death caused by

the heavily-mutated Omicron variantbut less effective in preventing transmission.With cases soaring, some countries have expanded Covid-19 vaccine booster programmes or shortened the gap between shots as governments scramble to shore up protection.In an interview with Israel's N12 News, Dr Bourla was asked whether he sees booster shots being administered every four to five months on a regular basis.

Read more: ST Foreign Desk »

#trending: Chinese cosplayer claims she was detained by police for wearing a kimono

SUZHOU, CHINA — In a video that went viral on Chinese social media over the weekend, men in what looked like police uniform can be heard shouting at a young Chinese woman dressed in a Japanese kimono, who is apparently in the midst of a cosplay photoshoot in Suzhou. Read more >>

straits_times Say someone who head a pharma company that produces a vaccine that is horseshit? straits_times 'So from a public health perspective, it is an ideal situation' - So, we adopt a public health policy based on what is said by a Big Pharma?

WHO advisory panel recommends extending use of Pfizer vaccine to 5-11 year oldsThe recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunisation held a meeting on Wednesday to evaluate the companies' vaccine. The vaccine is currently recommended for use in people aged 12 years and above. The recommended dosage for the younger population is 10 micrograms instead of 30 micrograms offered to those 12 years and older.

Sputnik V shows higher Omicron-antibody levels than Pfizer in preliminary studyMOSCOW — A small preliminary laboratory study has shown that levels of Omicron-neutralising antibodies of people vaccinated with Russia's Sputnik V vaccine did not decline as much as of those who had Pfizer shots. Will this be the next vaccine we use? Prepping the population? Sputnik hahhaha rubbish Kikkkklllll

It’s perfectly OK if work isn’t your true meaning in life, says S’porean CEOLearning to distill the things in life that are truly important. Guess anything's OK When Qasim was sharing his dreams on Facebook, he faced scrutiny, and one day he decided that he will delete all social media accounts. Then same night, Prophet Muhammad SAW came to his dream and advised him not to despair in Mercy of Allah SWT. More at What a misguided, arrogant and shortsighted thing to say. So out of touch with reality

Kakao Pay shares rebound after CEO, others step down amid stock options rowSEOUL : Shares in South Korean financial services firm Kakao Pay Corp jumped on Friday after the company said its CEO and two other executives were stepping down following a slump in the stock, amid fierce criticism of their exercising of stock options soon after the firm listed last November.The shares s

Boulben withdraws from race for Orange CEO post, le Figaro reportsPARIS : Verizon Chief Revenue Officer Frank Boulben has written to the board of Orange withdrawing from the race to head the French telecom firm, Le Figaro reported on Saturday. Sources told Reuters earlier this month that Boulben was one of three people on a shortlist of possible candidates. The others a

Boulben withdraws from race for Orange CEO post -FigaroPARIS : Verizon Chief Revenue Officer Frank Boulben has written to the board of Orange withdrawing from the race to head the French telecom firm, Le Figaro reported on Saturday. Sources told Reuters earlier this month that Boulben was one of three people on a shortlist of possible candidates. The others a

Copy to clipboard https://str.Read full article 21 January 2022, 2:11 pm · 1-min read FILE PHOTO: Children are being vaccinated against COVID-19 in Maintal near Frankfurt (Reuters) -The World Health Organization's advisory panel on Friday recommended extending the use of a reduced dosage of Pfizer and German partner BioNTech's COVID-19 vaccine to children aged 5 to 11 years old.The joint Russian-Italian study — funded by the Russian Direct Investment Fund, which markets Sputnik V abroad — compared the blood serum of people who had received the different vaccines.Online COMMENTARY:"Businesses and leaders able to connect with a greater purpose and legacy that their employees desire to leave behind will be the ultimate winners of the “Great Resignation.

sg/wAst JERUSALEM (REUTERS) - Pfizer Chief Executive Albert Bourla said on Saturday (Jan 23) that an annual Covid-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic. Pfizer/BioNtech's Covid-19 vaccine has shown to be effective against severe disease and death caused by the heavily-mutated Omicron variant but less effective in preventing transmission. The vaccine is currently recommended for use in people aged 12 years and above. With cases soaring, some countries have expanded Covid-19 vaccine booster programmes or shortened the gap between shots as governments scramble to shore up protection. It included 51 people vaccinated with Sputnik V and 17 after two shots of the Pfizer vaccine. In an interview with Israel's N12 News, Dr Bourla was asked whether he sees booster shots being administered every four to five months on a regular basis. "This age group (5-11) is in the lowest priority use group for vaccination except for children who have co-morbidities," SAGE chairman Alejandro Cravioto said. "This will not be a good scenario. But after more than four years on the New York Times (NYT) bestseller list in the “Advice and How-To” category, I started to wonder what I was missing.

What I'm hoping (is) that we will have a vaccine that you will have to do once a year," Dr Bourla said. (Reporting by Mrinalika Roy and Manojna Maddipatla in BengaluruEditing by Mark Heinrich and Alison Williams) TRENDING.2 per cent of the people vaccinated with Sputnik and in 56. "Once a year - it is easier to convince people to do it. It is easier for people to remember. "So from a public health perspective, it is an ideal situation. "Partnership of different platforms is the key. We are looking to see if we can create a vaccine that covers Omicron and doesn't forget the other variants and that could be a solution," Dr Bourla said. A world of certainty I grew up in a world where leaders like Jack Welch, the former CEO of GE, espoused a “take no prisoners” style towards leadership, where all leaders cared about was ascending to the apex job of their organisations, in a bid to become captains of industry.

Dr Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March. Citing three studies, the US Centres for Disease Control and Prevention (CDC) said on Friday that a third dose of an mRNA vaccine is key to fighting Omicron, providing 90 per cent protection against hospitalisation.boosting with Sputnik Light will help strengthen efficacy of other vaccines in light of combined Delta and Omicron challenge," the head of RDIF Kirill Dmitriev said in a statement. A preliminary study published by Israel's Sheba Medical Centre on Monday found that a fourth shot increases antibodies to even higher levels than the third but was likely not enough to fend off Omicron. Nonetheless, a second booster was still advised for high-risk groups, Sheba said. More On This Topic . Russia has so far officially recorded more than 1,600 cases of the variant and has mobilised its health system to tackle an increase in cases, but authorities said they realised that there are many more cases related to Omicron. One where a company did not have any relevance unless it was one of the top two in a particular industry or segment.